GL1X · GenesisL1 explorer

Research workbench

TGF-beta receptor type 1 kinase domain (T204D) in complex with 6-[4-(3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-YL]IMIDAZO[1,2-B]PYRIDAZINE-3-carbonitrile

Analyse TGF-beta receptor type 1 kinase domain (T204D) in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5QU0
Type
protein
Length
306 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.67
Source
Homo sapiens
Molecule
TGF-beta receptor type-1
EC
2.7.11.30
UniProt
P36897
Ligands
QMV
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · resolution 1.67 · 1 distinct chain · 40% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATGF-beta receptor type-1 (EC 2.7.11.30)protein30640% helix, 21% strandP36897

Ligands and binding sites

  • QMV · 6-[4-(3-chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl]imidazo[1,2-b]pyridazine-3-carbonitrile · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.740.9821empty
23230.670.8243QMV

Compared structures

  • 5QU0 · TGF-beta receptor type 1 kinase domain (T204D) in complex with 6-[4… · the same entry in another collection · chain A against A, TM-score 1.00
  • P36897 · AlphaFold monomer V2.0 prediction for TGF-beta receptor type-1 (P36897) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.